メインのコンテンツにスキップする

申し訳ございませんが、お客様のブラウザには完全に対応しておりませんオプションがありましたら、新しいバージョンにアップグレードするか、 Mozilla Firefox、 Microsoft Edge、Google Chrome、またはSafari 14以降をお使いください。これらが利用できない場合、またサポートが必要な場合は、フィードバックをお送りください。

この新ホームページへのフィードバックを歓迎します。ご意見をお寄せください新しいタブ/ウィンドウで開く

Elsevier
論文を投稿する

Conference speaker

Alan DT Barrett

ADB

Alan DT Barrett

Director, Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, USA

Alan DT Barrett, Ph.D., D.Sc (Hon) is Director of the Sealy Institute for Vaccine Sciences, Professor in the Department of Pathology, and is holder of the John Sealy Distinguished University Chair in Vaccinology at the University of Texas Medical Branch at Galveston. He obtained his PhD from the University of Warwick, completed a postdoctoral fellowship at the London School of Hygiene and Tropical Medicine, and became an academic at the University of Surrey (1985-1993). In 1993. Dr. Barrett moved to the University of Texas Medical Branch and became Director of the Sealy Center for Vaccine Development (2008), which was re-designated the Sealy Institute for Vaccine Sciences in 2017. He was elected Fellow of the International Society for Vaccines (2014), Fellow of the American Academy of Microbiology (2016), and was awarded an honorary Doctor of Science Degree from the University of Warwick (2018). His research interests are vaccine development of flaviviruses (dengue, Japanese encephalitis, West Nile, tick-borne encephalitis, yellow fever, and Zika). His research has resulted in him authoring more than 375 papers, reviews, commentaries, and book chapters. He has served on many World Health Organization committees, has been a member of multiple working groups of the CDC Advisory Committee on Immunization Practices, and was Co-Chair for a breakout group evaluating the Flaviviridae Family, NIH Workshop on Pandemic Preparedness. He is currently a member of the Vaccine Research, Development and Manufacturing Committee of the Coalition for Epidemic Preparedness Innovations. He is Founding Editor-in-Chief of Nature partner journal (npj) Vaccines (2015-present).